BioPharm International
August 01, 2012
Issue PDF
25
8
Advances in Protein Analysis
August 01, 2012
Disposables Advisor
25
8
There is no harmonized guidance on pre-use integrity testing of sterilizing filters, prompting discussion among users as to whether such testing is necessary.
August 01, 2012
Manufacturing Best Practices
25
8
A one-day sign off for batch records is considered a best practice in the industry.
August 01, 2012
Global Reports
25
8
After a series of government reforms, the Japanese pharma market is making a comeback.
August 01, 2012
Bioanalytical Best Practices
25
8
Recently developed immunoassay technology platforms reduce sample volume requirements and improve cycle times.
August 01, 2012
Regulatory Beat
25
8
Import controls and risk strategies aim to promote quality and spur new drug development.
August 01, 2012
Features
25
8
A look back at the history of orphan drugs in the industry.
August 01, 2012
Global Reports
25
8
A team from Northwestern University has demonstrated the feasibility of topical delivery of small interfering RNA (siRNA).
August 01, 2012
Perspectives on Outsourcing
25
8
Budgets for biopharma activities are gaining in select functional areas, except outsourcing.
August 01, 2012
Features
25
8
In HDX studies, data are produced across multiple time points, multiple species, and with replicates.
August 01, 2012
Features
25
8
The authors review the various analytical methods that can enable use of PAT.
August 01, 2012
Features
25
8
Current expectations in bioprocessing and a framework for using NMR to enhance a QbD approach.
August 01, 2012
Guest Editorial
25
8
Now that the Supreme Court has upheld the Affordable Care Act, what's next for biopharma?
August 01, 2012
Features
25
8
The author describes a methodology for developing a per product qualitative and semi-qualitative business case for applying QbD to a biopharmaceutical product.
August 01, 2012
Boot Camp Business Guide
25
8
Members from an ASQ working group provide analytical methods to enable PAT.